Trial · NCT04478071
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of Participants Who Are Classified 8 (Dead), 7 (Hospitalized, on Invasive Mechanical Ventilation or ECMO), or 6 (Hospitalized, on Non-invasive Ventilation or High Flow Oxygen Devices) on the NIAID Ordinal Scale | day 14 | National Institute of Allergy and Infectious Disease Ordinal Scale (NIAID-OS): 8 - Death 7 - Hospitalized, on invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO) 6 - Hospitalized, on non-invasive ventilation or high flow oxygen devices 5 - Hospitalized, requiring supplemental oxygen 4 - Hospitalized, not requiring supplemental oxygen - requiring ongoing care (COVID-19 related or otherwise) 3 - Hospitalized, not requiring supplemental oxygen - no longer requires ongoing medical care 2 - Not hospitalized, limitation on activities and/or requiring home oxygen 1 - Not hospitalized, no limitations on activities |
| Secondary | Number of Participants With a Total Score of 0 on the Modified Sequential Organ Failure Assessment (MSOFA) Scale | day 14 | Modified Sequential Organ Failure Assessment (MSOFA) scale: Each of 5 organ systems is given a score of 0 to 4.The MSOFA scale total score is the sum of the score for the 5 organ systems. Total score ranges from 0 to 20, a higher score indicates a worse outcome. Discharged patients will be assigned a score of 0 and dead patients a score of 20. |
| Other | Score on the Modified Sequential Organ Failure Assessment (MSOFA) Scale | day 7 | Modified Sequential Organ Failure Assessment (MSOFA) scale: Each of 5 organ systems is given a score of 0 to 4, as detailed below. The MSOFA scale total score is the sum of the score for the 5 organ systems. Discharged patients will be assigned a score of 0 and dead patients a score of 20. * Respiratory oxygen saturation(SpO2)/concentration of oxygen that a person inhales(FiO2): 0 (\> 400); 1 (≤ 400); 2 (≤ 315); 3 (≤ 235); 4 (≤ 150) * Liver: 0 (No scleral icterus or jaundice); 3 (Scleral icterus or jaundice) * Cardiovascular, hypotension: 0 (No hypotension); 1 (MAP \< 70 mm Hg); 2 (Dopamine ≤ 5 or dobutamine any dose); 3 (Dopamine \> 5, Epinephrine ≤ 0.1, Norepinephrine ≤ 0.1); 4 (Dopamine \> 15, Epinephrine \> 0.1, Norepinephrine \> 0.1) * Central Nervous System (CNS), Glasgow Coma Score: 0 (15), 1 (13 - 14); 2 (10 - 12); 3 (6 - 9); 4 (\< 6) * Renal, Creatinine mg/dL: 0 (\< 1.2); 1 (1.2 - 1.9); 2 (2.0 - 3.4); 3 (3.5 - 4.9); 4 (\> 5.0) |
| Other | Score on the Modified Sequential Organ Failure Assessment (MSOFA) Scale | day 14 | Modified Sequential Organ Failure Assessment (MSOFA) scale: Each of 5 organ systems is given a score of 0 to 4, as detailed below. The MSOFA scale total score is the sum of the score for the 5 organ systems. Discharged patients will be assigned a score of 0 and dead patients a score of 20. * Respiratory oxygen saturation(SpO2)/concentration of oxygen that a person inhales(FiO2): 0 (\> 400); 1 (≤ 400); 2 (≤ 315); 3 (≤ 235); 4 (≤ 150) * Liver: 0 (No scleral icterus or jaundice); 3 (Scleral icterus or jaundice) * Cardiovascular, hypotension: 0 (No hypotension); 1 (MAP \< 70 mm Hg); 2 (Dopamine ≤ 5 or dobutamine any dose); 3 (Dopamine \> 5, Epinephrine ≤ 0.1, Norepinephrine ≤ 0.1); 4 (Dopamine \> 15, Epinephrine \> 0.1, Norepinephrine \> 0.1) * Central Nervous System (CNS), Glasgow Coma Score: 0 (15), 1 (13 - 14); 2 (10 - 12); 3 (6 - 9); 4 (\< 6) * Renal, Creatinine mg/dL: 0 (\< 1.2); 1 (1.2 - 1.9); 2 (2.0 - 3.4); 3 (3.5 - 4.9); 4 (\> 5.0) |
| Other | Ventilator-free Survival | day 7 | |
| Other | Ventilator-free Survival | day 14 | |
| Other | Overall Survival | day 7 | |
| Other | Overall Survival | day 14 | |
| Other | Number of Participants With Hypotension | day 7 | Hypotension is defined as Mean Arterial Pressure (MAP) \<70 mm Hg or requirement for inotropes or vasopressors to maintain blood pressure. |
| Other | Number of Participants With Hypotension | day 14 | Hypotension is defined as Mean Arterial Pressure (MAP) \<70 mm Hg or requirement for inotropes or vasopressors to maintain blood pressure. |
| Other | Number of Participants With Acute Kidney Injury | day 7 | |
| Other | Number of Participants With Acute Kidney Injury | day 14 | |
| Other | Time to Hospital Discharge | From the time of hospital admission to hospital discharge (about 7 days) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04478071/registered